Cardiff Oncology Inc. (CRDF:NASDAQ) soared at $1.91, representing a gain of 23.2%. On Wed, Jan 18, 2023, CRDF:NASDAQ touched a New 2-Week High of $1.91. The stock appeared on our News Catalysts scanner on Tue, Jan 10, 2023 at 08:23 AM in the 'MISCELLANEOUS' category. From Wed, Jan 04, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Mon, Sep 12, 2022 at $3.31 with a volume of 1M+.
About Cardiff Oncology Inc. (CRDF:NASDAQ)
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic...
Top 10 Gainers:
- Ontrak Inc. (OTRK:NASDAQ), 94.78%
- Magic Empire Global Limited (MEGL:NASDAQ), 44.29%
- Energy Vault Holdings Inc Com Cl A (NRGV:NYSE), 34.83%
- Sigilon Therapeutics Inc. (SGTX:NASDAQ), 32.95%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 27.79%
- Sema4 Holdings Corp. (SMFR:NASDAQ), 26.78%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 25.71%
- Draganfly Inc. (DPRO:NASDAQ), 25.47%
- Celyad SA (CYAD:NASDAQ), 24.74%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 23.23%